Home|Journals|Articles by Year|Audio Abstracts

Original Research

Determination of prognostic significance of thrombocytosis on progression of renal cell carcinoma

Harshan T R Ravikumar, Mayank Jain Jain, Manohar C S, Keshavamurthy R.

Cited by 0 Articles

Introduction: Renal cell carcinoma (RCC) has varied presentations and outcomes. TNM Stage, pathological features and performance status are the established factors prognosticating the disease. Recently, role of thromobocytosis has been evaluated as simple, cost effective and accurate prognostic marker in RCC patients.
Objective: To study the effect of thromobocytosis in renal cell carcinoma on prognosis of disease.
Materials And Methods: A retrospective observational follow-up study of 142 patients with RCC from January 2007 to December 2017 was conducted at Institute of Nephrourology, Bengaluru (Karnataka). Platelet count more than 400000/mm3 was considered as thrombocytosis. The clinical parameters, tumour stage, grade, progression and survival of the disease were compared with respect to platelet count. Mean follow-up was 28 months (24-60 months). Patients time to disease progression and overall survival were studied with regard to thromobocytosis. Data was analysed using SPSS V26.0 using Chi square test, binary logistic and linear regression model and Kaplan Meir curve.
Results: Mean age was 54.59 years. Mean platelet count was 2, 45,292 /mm3 and mean tumour size was 7.67cm. Thromobocytosis correlates with total leucocyte count (p value

Key words: TNM stage, Renal Malignancy, followup, Platelet Count, Survival.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.